Ossium Health is also running the PRESERVE I trial to evaluate the safety and effectiveness of its deep-frozen bone marrow ...

Ossium Health’s PRESERVE I trial is evaluating the safety and effectiveness of its deep-frozen bone marrow from deceased ...

Positive preliminary outcomes were reported for the first leukemia patient treated with Ossium Health's organ donor bone ...

The goal of HCT is to cure an underlying malignancy or hematologic disorder. The procedure can be performed in an inpatient ...

The following is a summary of “Interventional antibiotic treatment replacing antibiotic prophylaxis during allogeneic hematopoietic stem cell transplantation is safe and leads to a reduction of ...

This study aimed to assess the effectiveness of a busulfan-based conditioning regimen in achieving reliable engraftment, high levels of donor chimerism, and acceptable toxicity profiles in patients ...

Researchers examine the association between patient-derived xenograft with recurrence and survival rates in triple negative ...

Lee Rubin, Feodor Price and colleagues at Harvard's Department of Stem Cell and Regenerative Biology have pioneered a groundbreaking 3D organoid culture method for generating large numbers of adult ...

The Division of Paediatric Haematology Oncology PHO at Safdarjung Hospital performed the first successful paediatric bone ...

The Centre-run Safdarjung Hospital has successfully conducted its first paediatric bone marrow transplant on a nine-year-old child who suffered from lymphoma. Lymphoma is a cancer of the lymphatic ...

Vor Bio reported positive data from its Phase I/II VBP101 study of trem-cel with Mylotarg in relapsed/refractory AML, showing ...

Vor Biopharma Inc. (NASDAQ:VOR) announced new clinical data from its ongoing Phase 1/2 VBP101 study of patients with relapsed ...